Home Healthcare Market: Growth, Size, Share, and Trends

7500+ companies worldwide approach us every year for their revenue growth initiatives

Global top 2000 strategist rely on us for their growth strategies.

80% of fortune 2000 companies rely on our research to identify new revenue sources.

30000 High Growth Opportunities

95% renewal rate

KNOW MORE

Home Healthcare Market by Product (Dialysis Equipment, Ventilators, HIV Test Kits, Hearing Aids, Activity Monitors), Service (Skilled Nursing, Infusion Therapy, Palliative Care), Indication (Cancer, Wound Care, Diabetes), & Region - Global Forecast to 2028

FREE BROCHURE FREE SAMPLE REPORT

Report Code: MD 1160 Jan, 2024, by marketsandmarkets.com

Market Growth Outlook Summary

The global home healthcare market, valued at US$230.0 billion in 2022, is forecasted to grow at a robust CAGR of 8.9%, reaching US$250 billion in 2023 and an impressive US$383 billion by 2028. The key drivers of this growth include the increasing elderly population, a rise in chronic conditions, the demand for cost-effective healthcare solutions, and advancements in home healthcare technology. However, challenges such as evolving reimbursement policies, limited insurance coverage, and concerns over patient safety may moderate growth to some extent.

Home Healthcare Market Size, Dynamics & Ecosystem

To know more about the assumptions used for this study, Request for Free Sample Report

Home Healthcare Market Dynamics

Driver: Increasing Elderly Population & Prevalence of Chronic Illnesses

According to the UN Department of Economic and Social Affairs, the global population over 65 is projected to grow from 771 million in 2022 to 1.6 billion by 2050. The number of people aged 80 and older will triple by 2050, significantly driving demand for healthcare services. With the elderly population more prone to chronic conditions, this demographic shift will boost demand for home healthcare services. Home healthcare provides a cost-effective solution by reducing hospital stays, readmissions, and travel time for appointments.

Opportunity: Expanding Role of Telehealth

Telehealth has become a critical component in home healthcare, offering continuous patient monitoring and early intervention through remote consultations. Telehealth services encompass virtual medical consultations, health management, and remote patient monitoring. These advancements provide patients with easier access to healthcare, improving outcomes and reducing the need for in-person visits. The growing use of telehealth is expected to enhance the efficiency and reach of home healthcare services.

Restraint: Limited Insurance Coverage

While many North American countries offer insurance coverage for home healthcare services, there are significant limitations, particularly for advanced equipment like multi-parameter monitors and telemetry. In regions like Europe and Asia, insurance coverage varies widely, with some countries only reimbursing post-hospital care rather than ongoing in-home healthcare, limiting the market's full potential.

Challenge: Shortage of Skilled Homecare Workers

There is an acute shortage of homecare professionals, a significant challenge in meeting the growing demand for home healthcare services. Projections from the US Bureau of Labor Statistics suggest a need for 924,000 new personal care aides and home health aides by 2031. This gap could restrict the market's growth unless workforce shortages are addressed, highlighting the need for innovative staffing solutions and workforce training in homecare services.

The home healthcare market is moderately consolidated, with major players such as Fresenius SE & Co. KGaA (Germany), Abbott (US), GE Healthcare (US), Koninklijke Philips NV (Netherlands), ResMed Inc. (US), Linde Plc (Ireland), and F. Hoffmann-La Roche Ltd. (Switzerland) holding a significant market share in 2022. These companies benefit from large-scale operations, substantial R&D investments, and established distribution networks, which present a barrier to new entrants in the market.

Home Healthcare Market Segmentation & Geographical Spread

For detailed assumptions in this study, download the PDF brochure

Therapeutic Products Lead the Home Healthcare Market

The home healthcare market is categorized into mobility care, therapeutic products, and testing & monitoring devices. In 2022, therapeutic products accounted for the largest share, driven by rising demand for equipment related to chronic conditions like respiratory diseases and kidney failure.

Skilled Nursing Services Hold the Largest Market Share by Service

Skilled nursing services, which include rehabilitation, hospice care, and respiratory therapies, dominate the home healthcare service sector. Patients prefer receiving care at home over institutional settings, driving the growth of skilled nursing services. This segment's market expansion is also supported by comprehensive insurance coverage.

Other Indications Drive Home Healthcare Growth

The home healthcare market is segmented by indications such as wound care, diabetes, cardiovascular diseases, and respiratory disorders. In 2022, the "Other Indications" category led the market, fueled by the increasing prevalence of HIV and sleep disorders, which require ongoing homecare management.

North America Leads the Global Home Healthcare Market

North America dominated the global home healthcare market in 2022, owing to a high incidence of chronic diseases and escalating healthcare costs. However, the Asia-Pacific region is expected to exhibit the highest growth rate during the forecast period, driven by an aging population and technological innovations in home healthcare.

The leading players in the home healthcare market include Fresenius SE & Co. KGaA (Germany), Abbott (US), GE HealthCare (US), Koninklijke Philips NV. (Netherlands), and ResMed Inc. (US). These companies maintain leadership through comprehensive product portfolios, substantial R&D investments, and expansive distribution networks.

Home Healthcare Market Report Scope

Report Metric	Details
Market Revenue Size in 2023	$250.0 Billion
Projected Revenue Size by 2028	$383.0 Billion
Industry Growth Rate	Poised to Grow at a CAGR of 8.9%
Market Driver	Sharp increase in the number of older people and the prevalence of chronic illnesses
Market Opportunity	Growing focus on newer technologies such as telehealth

This report categorizes the home healthcare market to forecast revenue and analyze trends in each of the following submarkets:

By Product

Therapeutic Products
Testing, Screening, and Monitoring Products
Mobility Care Products

By Service

Skilled Nursing
Rehabilitation Therapy
Hospice & Palliative Care
Unskilled Care
Respiratory Therapy
Infusion Therapy
Pregnancy Care

By Indication

Cancer
Respiratory Diseases
Movement Disorders
Cardiovascular Diseases & Hypertension
Pregnancy
Wound Care
Diabetes
Hearing Disorders
Other Indications

By Region

North America
- US
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
Rest of the World
- Latin America
- Middle East Africa

Recent Developments in the Home Healthcare Market

In August 2022, Fresenius Medical Care North America (FMCNA) acquired InterWell Health Brand (US) to strengthen expertise in kidney care value-based contracting and performance.
In August 2022, Contessa (US) partnered with Mount Sinai Health System (US) to offer a comprehensive range of home-based care services, including hospitalization at home and palliative care at home.
In July 2022, Invacre Corporation (US) introduced the Next Generation e-fix eco Power Assist Device designed to transform manual wheelchairs, enhancing mobility and independence for patients.

Frequently Asked Questions (FAQ):

What is the projected growth rate of the global home healthcare market between 2023 and 2028?

The global home healthcare market is projected to grow from USD 250 billion in 2023 to USD 383 billion by 2028, reflecting a CAGR of 8.9%.

What are the primary drivers of the home healthcare market?

The key drivers include the aging population, rising chronic illnesses, and growing demand for telehealth services, enabling remote care and monitoring.

What challenges does the home healthcare market face?

Challenges include limited insurance coverage for services and equipment, and a shortage of qualified homecare workers to meet growing demand.

Which segments dominate the home healthcare market?

In 2022, therapeutic products and skilled nursing services led the market, driven by the demand for chronic illness management and in-home care.

How is telehealth influencing the home healthcare market?

Telehealth enhances home healthcare by enabling continuous monitoring, virtual consultations, and timely interventions, reducing hospital visits.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

INTRODUCTION

RESEARCH METHODOLOGY

EXECUTIVE SUMMARY

PREMIUM INSIGHTS

MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS

DRIVERS

- Rapid growth in elderly population and rising incidence of chronic diseases

- Rising R&D investments

- Need for cost-effective healthcare delivery due to rising costs

- Increased preference for personalized care

RESTRAINTS

- Changing reimbursement policies

- Limited insurance coverage

- Patient safety concerns

OPPORTUNITIES

- Rising focus on telehealth

- Untapped developing regions

- Growing demand for home-use therapeutic devices

- Growing demand for home sleep apnea tests

- Rising preference for home hemodialysis treatment

CHALLENGES

- Shortage of home care workers

- Lack of supporting infrastructure
5.3 PRICING ANALYSIS

PRICING MODEL ANALYSIS
5.4 PATENT ANALYSIS

LIST OF KEY PATENTS
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM/MARKET MAP

HOME HEALTHCARE MARKET: ROLE IN ECOSYSTEM
5.8 PORTER’S FIVE FORCES ANALYSIS

PULSE OXIMETERS

- Threat of new entrants

- Threat of substitutes

- Bargaining power of suppliers

- Bargaining power of buyers

- Degree of competition

HEARING AIDS

- Threat of new entrants

- Threat of substitutes

- Bargaining power of buyers

- Bargaining power of suppliers

- Degree of competition
5.9 PESTLE ANALYSIS
5.10 REGULATORY LANDSCAPE

NORTH AMERICA

- US

- Canada

EUROPE

ASIA PACIFIC

- Japan

- China

- India
5.11 TRADE ANALYSIS

TRADE ANALYSIS FOR BLOOD PRESSURE MONITORS
5.12 TECHNOLOGY ANALYSIS
5.13 KEY CONFERENCES & EVENTS IN 2023–2024
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.15 KEY STAKEHOLDERS & BUYING CRITERIA

KEY STAKEHOLDERS IN BUYING PROCESS

BUYING CRITERIA
5.16 CASE STUDY ANALYSIS

CASE STUDY: FUTURE OF HOME HEALTH PROJECT

HOME HEALTHCARE MARKET, BY PRODUCT

6.1 INTRODUCTION
6.2 THERAPEUTIC PRODUCTS

DIALYSIS EQUIPMENT

- Dialysis equipment to hold largest market share

WOUND CARE PRODUCTS

- Decreased costs and higher convenience and comfort to drive market

IV EQUIPMENT

- Accuracy and growing target disease prevalence to ensure market growth

SLEEP APNEA THERAPEUTIC DEVICES

- Increasing patient preference for home-based sleep tests to fuel market

INSULIN DELIVERY DEVICES

- High incidence of diabetes to drive market

OXYGEN DELIVERY SYSTEMS

- Technological advancements in oxygen therapy products to drive market

INHALERS

- High incidence of asthma to boost market

NEBULIZERS

- Effectiveness over oral dosages to push preference for nebulizers

VENTILATORS

- Convenience and comfort to sustain end-user preference

OTHER THERAPEUTIC PRODUCTS
6.3 TESTING, SCREENING, AND MONITORING PRODUCTS

BLOOD GLUCOSE MONITORS

- Increasing prevalence of diabetes to drive market growth

HEARING AIDS

- High incidence of hearing impairment to drive market

ACTIVITY MONITORS & WRISTBANDS

- Increasing prevalence of chronic diseases to bolster demand for activity monitors

ECG/EKG DEVICES

- High prevalence of CVD to support demand

TEMPERATURE MONITORING DEVICES

- Technological innovations and increasing awareness to drive growth

HEART RATE MONITORS

- Continuous cardiac parameter monitoring capabilities to drive demand

PULSE OXIMETERS

- Rising disease incidence and wide usage of pulse oximetry to ensure strong demand

OVULATION & PREGNANCY TEST KITS

- Privacy, convenience, accessibility, and quick results to drive market

BLOOD PRESSURE MONITORS

- Rising patient population for hypertension and CVD to drive market

HIV TEST KITS

- Rising prevalence of HIV to drive market

FETAL MONITORING DEVICES

- Remote-based care by portable fetal monitoring systems to drive market growth

HOLTER & EVENT MONITORS

- Rising awareness of preventive care and technological advancements to drive market

DRUG & ALCOHOL TEST KITS

- Rising consumption of drugs among teens to support market growth

COAGULATION MONITORING PRODUCTS

- Rising use of anticoagulant therapy and availability of home-use kits to drive market

PEAK FLOW METERS

- High portability and cost-efficiency to ensure adoption

COLON CANCER TEST KITS

- High incidence of colorectal cancer to drive market growth

EEG DEVICES

- Wide patient population for epilepsy to drive market for EEG devices

HOME SLEEP TESTING DEVICES

- Cost-effectiveness of home-based sleep tests to fuel growth

CHOLESTEROL TESTING PRODUCTS

- Rising obesity levels and CVD incidence to support market

HOME HBA1C TEST KITS

- High incidence of diabetes to drive market
6.4 MOBILITY CARE PRODUCTS

WHEELCHAIRS

- Increased preference for wheelchairs to boost demand

MOBILITY SCOOTERS

- High cost to affect end-user adoption

WALKERS & ROLLATORS

- Difficulties in using walkers and availability of alternatives to restrain market

CRUTCHES

- High preference for axilla crutches to support demand

CANES

- Wide usage of canes to drive market

HOME HEALTHCARE MARKET, BY SERVICE

129

7.1 INTRODUCTION
7.2 SKILLED NURSING SERVICES

SKILLED NURSING SERVICES TO DOMINATE MARKET
7.3 REHABILITATION THERAPY SERVICES

RISING DEMAND, GROWING GERIATRIC POPULATION, AND INCREASING DISEASE INCIDENCE TO BOOST DEMAND
7.4 HOSPICE & PALLIATIVE CARE SERVICES

RISING GERIATRIC POPULATION TO DRIVE DEMAND
7.5 UNSKILLED CARE SERVICES

COST-EFFECTIVENESS TO DRIVE GROWTH
7.6 RESPIRATORY THERAPY SERVICES

GROWING PREVALENCE OF RESPIRATORY DISORDERS TO DRIVE MARKET
7.7 INFUSION THERAPY SERVICES

SAFETY AND EFFECTIVENESS OF HOME INFUSION TO DRIVE DEMAND
7.8 PREGNANCY CARE SERVICES

NEED FOR BETTER MANAGEMENT OF HIGH-RISK PREGNANCIES AND COMPLICATIONS TO ENSURE MARKET GROWTH

HOME HEALTHCARE MARKET, BY INDICATION

139

8.1 INTRODUCTION
8.2 CANCER

CANCER TO DOMINATE INDICATIONS MARKET
8.3 RESPIRATORY DISEASES

RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET
8.4 MOVEMENT DISORDERS

GROWING GERIATRIC POPULATION TO DRIVE DEMAND FOR THERAPY EQUIPMENT
8.5 PREGNANCY

RISING FOCUS ON BETTER CARE & MONITORING DURING PREGNANCY TO DRIVE MARKET GROWTH
8.6 CVD & HYPERTENSION

RISING INCIDENCE OF HYPERTENSION & CARDIOVASCULAR DISEASES TO DRIVE GROWTH
8.7 WOUND CARE

GROWING NUMBER OF ROAD ACCIDENTS AND TRAUMA INJURIES TO DRIVE MARKET
8.8 DIABETES

INCREASING INCIDENCE OF DIABETES TO PROPEL MARKET GROWTH
8.9 HEARING DISORDERS

WORLDWIDE INCREASE IN HEARING DISABILITIES TO ENSURE SUSTAINED GROWTH
8.10 OTHER INDICATIONS

HOME HEALTHCARE MARKET, BY REGION

150

9.1 INTRODUCTION
9.2 NORTH AMERICA

NORTH AMERICA: RECESSION IMPACT

US

- US to dominate North American home healthcare market

CANADA

- Rising geriatric population to drive market
9.3 EUROPE

EUROPE: RECESSION IMPACT

GERMANY

- Germany to retain market leadership in Europe

UK

- Rising burden of chronic diseases to boost market growth

FRANCE

- Government support and initiatives taken by market players to boost market

ITALY

- Rising geriatric population and favorable government policy to drive market

SPAIN

- Rising geriatric population and incidence of chronic conditions to drive market growth

REST OF EUROPE
9.4 ASIA PACIFIC

ASIA PACIFIC: RECESSION IMPACT

JAPAN

- Japan to command largest share of APAC market

CHINA

- Healthcare development and reforms to drive market growth

INDIA

- Increasing target patient population to drive market

REST OF ASIA PACIFIC
9.5 REST OF THE WORLD

REST OF THE WORLD: RECESSION IMPACT

LATIN AMERICA

- Aging population to favor market growth

MIDDLE EAST & AFRICA

- GCC Countries

- Rest of the Middle East & Africa

COMPETITIVE LANDSCAPE

255

10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN

OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS
10.3 REVENUE SHARE ANALYSIS
10.4 MARKET SHARE ANALYSIS
10.5 COMPANY EVALUATION MATRIX

STARS

EMERGING LEADERS

PERVASIVE PLAYERS

PARTICIPANTS

COMPANY FOOTPRINT
10.6 START-UP/SME EVALUATION MATRIX

PROGRESSIVE COMPANIES

RESPONSIVE COMPANIES

DYNAMIC COMPANIES

STARTING BLOCKS

COMPETITIVE BENCHMARKING
10.7 COMPETITIVE SCENARIO

PRODUCT LAUNCHES & APPROVALS

DEALS

OTHER DEVELOPMENTS

COMPANY PROFILES

268

11.1 KEY PLAYERS

FRESENIUS SE & CO. KGAA

- Business overview

- Products/Solutions/Services offered

- Recent developments

- MnM view

ABBOTT

- Business overview

- Products/Solutions/Services offered

- Recent developments

- MnM view

LINDE PLC

- Business overview

- Products/Solutions/Services offered

- MnM view

F. HOFFMANN-LA ROCHE

- Business overview

- Products/Solutions/Services offered

- Recent developments

- MnM view

RESMED

- Business overview

- Products/Solutions/Services offered

- Recent developments

- MnM view

KONINKLIJKE PHILIPS

- Business overview

- Products/Solutions/Services offered

- Recent developments

GE HEALTHCARE

- Business overview

- Products/Solutions/Services offered

- Recent developments

A&D COMPANY

- Business overview

- Products/Solutions/Services offered

- Recent developments

INVACARE CORPORATION

- Business overview

- Products/Solutions/Services offered

- Recent developments

AMEDISYS

- Business overview

- Products/Solutions/Services offered

- Recent developments

LHC GROUP

- Business overview

- Products/Solutions/Services offered

- Recent developments

OMRON CORPORATION

- Business overview

- Products/Solutions/Services offered

- Recent developments
11.2 OTHER PLAYERS

BAYADA HOME HEALTH CARE

DRIVE DEVILBISS HEALTHCARE LIMITED

SUNRISE MEDICAL

ROMA MEDICAL

CAREMAX REHABILITATION EQUIPMENT

VITALOGRAPH

ADVITA PFLEGEDIENST

RENAFAN GMBH

CONTEC MEDICAL SYSTEMS

B. BRAUN MELSUNGEN AG

BAXTER INTERNATIONAL

MEDLINE INDUSTRIES

ADVIN HEALTH CARE

APPENDIX

333

12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS

LIST OF TABLES

TABLE 1 INCLUSIONS AND EXCLUSIONS
TABLE 2 KEY DATA FROM PRIMARY SOURCES
TABLE 3 GERIATRIC POPULATION, 2022 VS. 2050 (MILLION)
TABLE 4 PRODUCT LAUNCHES
TABLE 5 AVERAGE SELLING PRICE OF PRODUCTS OFFERED BY KEY PLAYERS (2023)
TABLE 6 AVERAGE SELLING PRICE OF HOME HEALTHCARE PRODUCTS, BY REGION (2023)
TABLE 7 PULSE OXIMETERS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 8 HEARING AIDS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 14 US FDA: CLASSIFICATION OF MEDICAL DEVICES
TABLE 15 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 16 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 17 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND REVIEWING BODIES
TABLE 18 CHINA: CLASSIFICATION OF MEDICAL DEVICES
TABLE 19 IMPORT DATA FOR BLOOD PRESSURE MONITORS, BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 20 EXPORT DATA FOR BLOOD PRESSURE MONITORS, BY COUNTRY, 2017–2021 (USD MILLION)
TABLE 21 HOME HEALTHCARE MARKET: KEY CONFERENCES & EVENTS, 2023–2024
TABLE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS
TABLE 23 KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS
TABLE 24 HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 25 KEY THERAPEUTIC PRODUCTS OFFERED
TABLE 26 THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 27 THERAPEUTIC PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 28 DIALYSIS EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 29 WOUND CARE PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 30 IV EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 31 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 32 INSULIN DELIVERY DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 33 OXYGEN DELIVERY SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 34 INHALERS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 35 NEBULIZERS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 36 VENTILATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 37 OTHER THERAPEUTIC PRODUCTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 38 KEY TESTING, SCREENING, AND MONITORING PRODUCTS OFFERED
TABLE 39 TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 40 TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 41 BLOOD GLUCOSE MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 42 HEARING AIDS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 43 ACTIVITY MONITORS & WRISTBANDS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 44 ECG/EKG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 45 TEMPERATURE MONITORING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 46 HEART RATE MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 47 PULSE OXIMETERS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 48 OVULATION & PREGNANCY TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 49 BLOOD PRESSURE MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 50 HIV TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 51 FETAL MONITORING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 52 HOLTER & EVENT MONITORS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 53 DRUG & ALCOHOL TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 54 COAGULATION MONITORING PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 55 PEAK FLOW METERS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 56 COLON CANCER TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 57 EEG DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 58 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 59 CHOLESTEROL TESTING PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 60 HOME HBA1C TEST KITS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 61 KEY MOBILITY CARE PRODUCTS AVAILABLE IN THE MARKET
TABLE 62 MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 63 MOBILITY CARE PRODUCTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 64 WHEELCHAIRS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 65 MOBILITY SCOOTERS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 66 WALKERS & ROLLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 67 CRUTCHES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 68 CANES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 69 US: AVERAGE SENIOR CARE COST, BY TYPE, 2022
TABLE 70 HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 71 HOME HEALTHCARE SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 72 SKILLED NURSING SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 73 REHABILITATION THERAPY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 74 HOSPICE & PALLIATIVE CARE SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 75 UNSKILLED SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 76 RESPIRATORY THERAPY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 77 INFUSION THERAPY SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 78 PREGNANCY CARE SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 79 HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 80 HOME HEALTHCARE INDICATIONS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 81 INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
TABLE 82 HOME HEALTHCARE MARKET FOR CANCER, BY REGION, 2021–2028 (USD MILLION)
TABLE 83 HOME HEALTHCARE MARKET FOR RESPIRATORY DISEASES, BY REGION, 2021–2028 (USD MILLION)
TABLE 84 HOME HEALTHCARE MARKET FOR MOVEMENT DISORDERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 85 HOME HEALTHCARE MARKET FOR PREGNANCY, BY REGION, 2021–2028 (USD MILLION)
TABLE 86 HOME HEALTHCARE MARKET FOR CVD & HYPERTENSION, BY REGION, 2021–2028 (USD MILLION)
TABLE 87 HOME HEALTHCARE MARKET FOR WOUND CARE, BY REGION, 2021–2028 (USD MILLION)
TABLE 88 HOME HEALTHCARE MARKET FOR DIABETES, BY REGION, 2021–2028 (USD MILLION)
TABLE 89 HOME HEALTHCARE MARKET FOR HEARING DISORDERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 90 HOME HEALTHCARE MARKET FOR OTHER INDICATIONS, BY REGION, 2021–2028 (USD MILLION)
TABLE 91 HOME HEALTHCARE MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 92 NORTH AMERICA: HOME HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 93 NORTH AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 94 NORTH AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 95 NORTH AMERICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 96 NORTH AMERICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 97 NORTH AMERICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 98 NORTH AMERICA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 99 NORTH AMERICA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 100 US: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 101 US: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 102 US: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 103 US: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 104 US: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 US: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 106 US: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 107 CANADA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 108 CANADA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 109 CANADA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 110 CANADA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 111 CANADA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 112 CANADA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 113 CANADA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 114 EUROPE: HOME HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 115 EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 116 EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 117 EUROPE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 118 EUROPE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 119 EUROPE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 EUROPE: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 121 EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 122 GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 123 GERMANY: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 124 GERMANY: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 125 GERMANY: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 126 GERMANY: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 127 GERMANY: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 128 GERMANY: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 129 UK: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 130 UK: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 131 UK: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 UK: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 133 UK: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 134 UK: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 135 UK: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 136 FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 137 FRANCE: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 138 FRANCE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 139 FRANCE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 140 FRANCE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 141 FRANCE: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 142 FRANCE: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 143 ITALY: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 144 ITALY: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 145 ITALY: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 146 ITALY: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 147 ITALY: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 148 ITALY: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 149 ITALY: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 150 SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 151 SPAIN: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 152 SPAIN: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 153 SPAIN: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 154 SPAIN: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 155 SPAIN: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 156 SPAIN: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 157 REST OF EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 158 REST OF EUROPE: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 159 REST OF EUROPE: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 160 REST OF EUROPE: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 161 REST OF EUROPE: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 162 REST OF EUROPE: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 163 REST OF EUROPE: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 164 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 165 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 166 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 167 ASIA PACIFIC: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 168 ASIA PACIFIC: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 169 ASIA PACIFIC: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 170 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 171 ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 172 JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 173 JAPAN: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 174 JAPAN: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 175 JAPAN: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 176 JAPAN: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 177 JAPAN: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 178 JAPAN: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 179 CHINA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 180 CHINA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 181 CHINA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 182 CHINA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 183 CHINA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 184 CHINA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 185 CHINA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 186 INDIA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 187 INDIA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 188 INDIA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 189 INDIA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 190 INDIA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 191 INDIA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 192 INDIA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 193 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 194 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 195 REST OF ASIA PACIFIC: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 196 REST OF ASIA PACIFIC: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 197 REST OF ASIA PACIFIC: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 198 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 199 REST OF ASIA PACIFIC: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 200 ROW: HOME HEALTHCARE MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 201 ROW: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 202 ROW: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 203 ROW: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 204 ROW: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 205 ROW: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 206 ROW: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 207 ROW: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 208 LATIN AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 209 LATIN AMERICA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 210 LATIN AMERICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 211 LATIN AMERICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 212 LATIN AMERICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 213 LATIN AMERICA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 214 LATIN AMERICA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 216 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 220 MIDDLE EAST & AFRICA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 221 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 222 MIDDLE EAST & AFRICA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 223 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 224 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 225 GCC COUNTRIES: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 226 GCC COUNTRIES: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 227 GCC COUNTRIES: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 228 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 229 GCC COUNTRIES: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 230 ROMEA: HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 231 ROMEA: HOME HEALTHCARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 232 ROMEA: THERAPEUTIC PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 233 ROMEA: TESTING, SCREENING, AND MONITORING PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 234 ROMEA: MOBILITY CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 235 ROMEA: HOME HEALTHCARE MARKET, BY SERVICE, 2021–2028 (USD MILLION)
TABLE 236 ROMEA: HOME HEALTHCARE MARKET, BY INDICATION, 2021–2028 (USD MILLION)
TABLE 237 OVERVIEW OF STRATEGIES DEPLOYED BY KEY HOME HEALTHCARE PRODUCT MANUFACTURERS
TABLE 238 HOME HEALTHCARE MARKET: DEGREE OF COMPETITION
TABLE 239 PRODUCT FOOTPRINT (FIVE PLAYERS)
TABLE 240 REGIONAL FOOTPRINT (FIVE PLAYERS)
TABLE 241 COMPETITIVE BENCHMARKING OF KEY PLAYERS
TABLE 242 HOME HEALTHCARE MARKET: DETAILED LIST OF KEY START-UPS/SMES
TABLE 243 COMPETITIVE BENCHMARKING OF START-UPS/SMES
TABLE 244 HOME HEALTHCARE MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 245 HOME HEALTHCARE MARKET: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 246 HOME HEALTHCARE MARKET: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
TABLE 247 FRESENIUS SE & CO. KGAA: COMPANY OVERVIEW
TABLE 248 FRESENIUS SE & CO. KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 249 FRESENIUS SE & CO. KGAA: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 250 FRESENIUS SE & CO. KGAA: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 251 FRESENIUS SE & CO. KGAA: OTHER DEVELOPMENTS (JANUARY 2020–DECEMBER 2023)
TABLE 252 ABBOTT: COMPANY OVERVIEW
TABLE 253 ABBOTT: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 254 ABBOTT: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 255 ABBOTT: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 256 LINDE: COMPANY OVERVIEW
TABLE 257 LINDE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 258 F. HOFFMANN-LA ROCHE: COMPANY OVERVIEW
TABLE 259 F. HOFFMAN-LA ROCHE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 260 F. HOFFMAN-LA ROCHE: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
TABLE 261 F. HOFFMANN-LA ROCHE: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 262 RESMED: COMPANY OVERVIEW
TABLE 263 RESMED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 264 RESMED: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
TABLE 265 RESMED: DEALS
TABLE 266 KONINKLIJKE PHILIPS: COMPANY OVERVIEW
TABLE 267 KONINKLIJKE PHILIPS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 268 KONINKLIJKE PHILIPS: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
TABLE 269 KONINKLIJKE PHILIPS: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 270 GE HEALTHCARE: COMPANY OVERVIEW
TABLE 271 GE HEALTHCARE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 272 GE HEALTHCARE: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 273 A&D COMPANY: COMPANY OVERVIEW
TABLE 274 A&D COMPANY: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 275 A&D COMPANY: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
TABLE 276 INVACARE CORPORATION: COMPANY OVERVIEW
TABLE 277 INVACARE CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 278 INVACARE CORPORATION: PRODUCT LAUNCHES (JANUARY 2020–DECEMBER 2023)
TABLE 279 AMEDISYS: COMPANY OVERVIEW
TABLE 280 AMEDISYS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 281 AMEDISYS: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 282 LHC GROUP: COMPANY OVERVIEW
TABLE 283 LHC GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 284 LHC GROUP: DEALS (JANUARY 2020–DECEMBER 2023)
TABLE 285 OMRON CORPORATION: COMPANY OVERVIEW
TABLE 286 OMRON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
TABLE 287 OMRON CORPORATION: PRODUCT LAUNCHES & APPROVALS (JANUARY 2020–DECEMBER 2023)
TABLE 288 OMRON CORPORATION: DEALS (JANUARY 2020–DECEMBER 2023)

LIST OF FIGURES

FIGURE 1 HOME HEALTHCARE MARKET: RESEARCH DESIGN METHODOLOGY
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS (HOME HEALTHCARE MARKET)
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 6 HOME HEALTHCARE MARKET: TOP-DOWN APPROACH
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 HOME HEALTHCARE MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD BILLION)
FIGURE 9 HOME HEALTHCARE MARKET, BY PRODUCT, 2023 VS. 2028 (USD BILLION)
FIGURE 10 HOME HEALTHCARE MARKET, BY SERVICE, 2023 VS. 2028 (USD BILLION)
FIGURE 11 HOME HEALTHCARE MARKET, BY INDICATION, 2023 VS. 2028 (USD BILLION)
FIGURE 12 HOME HEALTHCARE MARKET: GEOGRAPHICAL SNAPSHOT
FIGURE 13 RISING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH
FIGURE 14 JAPAN AND CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 15 APAC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 16 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
FIGURE 17 HOME HEALTHCARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 18 PATENT ANALYSIS FOR TEMPERATURE MONITORING DEVICES (JANUARY 2013–DECEMBER 2022)
FIGURE 19 VALUE CHAIN ANALYSIS: MAJOR VALUE-ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
FIGURE 20 HOME HEALTHCARE MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 21 HOME HEALTHCARE MARKET: ECOSYSTEM/MARKET MAP
FIGURE 22 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
FIGURE 23 APPROVAL PROCESS FOR MEDICAL DEVICES IN CANADA
FIGURE 24 CE APPROVAL PROCESS IN EUROPE FOR MEDICAL DEVICES
FIGURE 25 REVENUE SHIFT IN HOME HEALTHCARE
FIGURE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF HOME HEALTHCARE PRODUCTS
FIGURE 27 KEY BUYING CRITERIA FOR HOME HEALTHCARE PRODUCTS
FIGURE 28 NORTH AMERICA: HOME HEALTHCARE MARKET SNAPSHOT
FIGURE 29 APAC: HOME HEALTHCARE MARKET SNAPSHOT
FIGURE 30 REVENUE SHARE ANALYSIS OF TOP PLAYERS
FIGURE 31 HOME HEALTHCARE MARKET SHARE ANALYSIS (2022)
FIGURE 32 HOME HEALTHCARE MARKET: COMPANY EVALUATION MATRIX, 2022
FIGURE 33 COMPANY FOOTPRINT (FIVE COMPANIES)
FIGURE 34 HOME HEALTHCARE MARKET: START-UP/SME EVALUATION MATRIX, 2022
FIGURE 35 FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT (2022)
FIGURE 36 ABBOTT: COMPANY SNAPSHOT (2022)
FIGURE 37 LINDE: COMPANY SNAPSHOT (2022)
FIGURE 38 F. HOFFMANN-LA ROCHE: COMPANY SNAPSHOT (2022)
FIGURE 39 RESMED: COMPANY SNAPSHOT (2022)
FIGURE 40 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT (2022)
FIGURE 41 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
FIGURE 42 A&D COMPANY: COMPANY SNAPSHOT (2022)
FIGURE 43 INVACARE CORPORATION: COMPANY SNAPSHOT (2022)
FIGURE 44 AMEDISYS: COMPANY SNAPSHOT (2022)
FIGURE 45 LHC GROUP: COMPANY SNAPSHOT (2022)
FIGURE 46 OMRON CORPORATION: COMPANY SNAPSHOT (2022)

The objective of the study is analyzing the key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies. To track companies’ developments such as acquisitions, product launches, expansions, agreements and partnerships of the leading players, the competitive landscape of the home healthcare market to analyzes market players on various parameters within the broad categories of business and product strategy. Top-down and bottom-up approaches were used to estimate the market size. To estimate the market size of segments and subsegments the market breakdown and data triangulation were used.

The four steps involved in estimating the market size are

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative and quantitative information as well as assess prospects.

The following is a breakdown of the primary respondents:

Breakdown of Primary Participants:

Home Healthcare Market Size, and Share

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2: Companies are classified into tiers based on their total revenues. As of 2022, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = <USD 10 million.

To know about the assumptions considered for the study, download the pdf brochure

COMPANY NAME	DESIGNATION
Abbott	Marketing Manager
Resmed	Senior Product Manager
GE Healthcare	Marketing Manager

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the home healthcare market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

The key players in the industry have been identified through extensive secondary research
The revenues generated by leading players operating in the home healthcare market have been determined through primary and secondary research
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Global Home healthcare Market Size: Bottom-Up Approach

Home Healthcare Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Global Home healthcare Market Size: Top-Down Approach

Home Healthcare Market Size, and Share

Data Triangulation

After arriving at the overall market size applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Home healthcare refers to the medical attention, care and support provided to patients at residences by licensed healthcare workers, such as nurses, home health aides, and personal care aides. The home healthcare market includes products and services that can be set up remotely at patient’s home.

Key Stakeholders

Senior Management
End User
Finance/Procurement Department
R&D Department

Report Objectives

To define, describe, segment, and forecast the global home healthcare market, by products, service, indication, and region
To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall home healthcare market
To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

Available Customizations

MarketsandMarkets offers the following customizations for this market report

Country Information

Additional country-level analysis of the home healthcare market

Company profiles

Additional five company profiles of players operating in the home healthcare market.

Product Analysis

Product matrix, which provides a detailed comparison of the product portfolio of each company in the home healthcare market

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.